Gao and colleges had reported that IspD was also the key enzyme in the MEP pathway in Mycobacterium tuberculosis, which causes tuberculosis in humans, and was selected as a chemo- therapeutic target to inhibit the mycobacterium growth [42]. This evidence concerns the gene CRPPA and tuberculosis.